Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

methylbenzethonium chloride

Known as: methylbenzethonium chloride [Chemical/Ingredient] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
BACKGROUND Pentavalent antimonial drugs are the most prescribed treatment for American cutaneous and mucocutaneous leishmaniasis… Expand
  • table 1
  • table 1
Is this relevant?
Highly Cited
2001
Highly Cited
2001
A double-blind, randomized trial was undertaken in Guatemala to determine the therapeutic efficacy of an ointment for the… Expand
  • table 1
  • figure 1
  • table 2
Is this relevant?
1999
1999
Cutaneous leishmaniasis is presently treated with 20 days of parenteral therapy with a frequently toxic drug (antimony). Topical… Expand
Is this relevant?
1998
1998
We determined the efficacy of the combination of the topical formulation 15% paromomycin sulfate/12% methylbenzethonium chloride… Expand
  • table 1
Is this relevant?
1995
1995
Colombian patients with New World cutaneous leishmaniasis were treated with a combination of a topical formulation (15… Expand
Is this relevant?
1994
1994
Fifty-two patients with American cutaneous leishmaniasis (ACL) from the Pacific coast of Ecuador were treated topically with an… Expand
Is this relevant?
Highly Cited
1992
Highly Cited
1992
BACKGROUND A controlled study of the efficacy of topical paromomycin sulfate (PR) and methylbenzethonium chloride (MBCl) in… Expand
Is this relevant?
1986
1986
Methylbenzethonium chloride (MBCl) decreased the growth of Leishmania major promastigotes and amastigotes in vitro. This decrease… Expand
Is this relevant?
1986
1986
Sixty-seven patients, 19 females and 48 males, 4-66 years old, suffering from lesions of cutaneous leishmaniasis were treated… Expand
Is this relevant?
1985
1985
A propos de 2 observations. Resultats satisfaisants: amelioration clinique, disparition progressive des parasites et… Expand
Is this relevant?